ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

OSIP Osi Pharmaceuticals Inc. (MM)

57.49
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
Osi Pharmaceuticals Inc. (MM) NASDAQ:OSIP NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 57.49 0 01:00:00

OSI Pharmaceuticals to Announce First Quarter 2010 Financial Results on April 22, 2010

14/04/2010 3:00pm

Business Wire


Osi Pharmaceuticals (NASDAQ:OSIP)
Historical Stock Chart


From Jul 2019 to Jul 2024

Click Here for more Osi Pharmaceuticals Charts.

OSI Pharmaceuticals, Inc. (Nasdaq: OSIP) announced today that its first quarter 2010 financial results will be released on April 22, 2010, after the markets close. Following the announcement, OSI’s management will host a live conference call and webcast at 5:00 p.m. Eastern Time to review the Company’s financial results, product portfolio and business developments.

To access the live webcast or the archive via the Internet, log on to www.osip.com. Please connect to the Company's website at least 15 minutes prior to the conference call to ensure adequate time for any software download that may be needed to access the webcast. Alternatively, please call 1-888-378-4350 (U.S.) or 1-719-457-2710 (international) to listen to the call. The conference ID number for the live call is 5184529. Telephone replay is available approximately two hours after the call. To access the replay, please call 1-888-203-1112 (U.S.) or 1-719-457-0820 (international). The conference ID number for the replay is 5184529.

About OSI Pharmaceuticals

OSI Pharmaceuticals is committed to "shaping medicine and changing lives" by discovering, developing and commercializing high-quality, novel and differentiated targeted medicines designed to extend life and improve the quality of life for patients with cancer and diabetes/obesity. For additional information about OSI, please visit http://www.osip.com.

1 Year Osi Pharmaceuticals Chart

1 Year Osi Pharmaceuticals Chart

1 Month Osi Pharmaceuticals Chart

1 Month Osi Pharmaceuticals Chart

Your Recent History

Delayed Upgrade Clock